mRNA quality control identified as novel drug target for Alzheimer’s and related dementias
Novel approach identified to tackle metabolic diseases.
Treatment could aim to raise levels of a neuroprotective molecule, studies hint.
San Antonio researchers identify a new target for drug development.
Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism through which two antiviral genes, when mutated, promote a childhood cancer called pediatric myelodysplastic syndrome (MDS).
A brief, five-session treatment for post-traumatic stress disorder (PTSD) called Written Exposure Therapy is as effective as a longer, gold-standard treatment for military service members, a new study shows.
UT Health San Antonio researchers compared results in less-severe and severe COVID-19 cases one and five months after symptom onset.
Doctoral student’s research suggests difficulty of translating longevity interventions from lower species to mammals
Protection is afforded infants against disease-causing bacteria
Compound limits magnesium transport in cellular power plants called mitochondria.
Obesity in midlife and in women most closely linked to dementia
Drug target that revs up energy expenditure, reduces appetite identified
Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells
Drug target that revs up energy expenditure, reduces appetite identified
Researchers discover toxic process involving ‘jumping genes’
The NIA Interventions Testing Program, including UT Health San Antonio, collaborated with peers in Tennessee and Switzerland.
No one individual has done more to demonstrate the multifaceted nature of type 2 diabetes than Ralph DeFronzo
For teenager Arhan Rao, repurposing an antidepressant drug to treat cancer is the opening act in a career of serving patients by finding new ways to stop tumors.
Holy mackerel! Could eating salmon, cod, tuna, herring or sardines keep our brains healthy and our thinking agile in middle age? New research makes this connection.
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes